Overcoming the solubility crisis: a solvent-free method to enhance drug bioavailability
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-May-2026 15:16 ET (15-May-2026 19:16 GMT/UTC)
Many promising drug molecules fail to reach patients because they do not dissolve well enough in water, limiting their effectiveness when taken orally. Now, researchers from Japan investigated an innovative method that uses sublimation to load drugs into a mesoporous silica carrier without relying on organic solvents. Using ibuprofen as a model compound, they showed that this approach can produce formulations with significantly enhanced solubility, offering a cleaner and more sustainable strategy for drug development.
How comprehensive is our healthcare system, and who is being left behind? In this study, The University of Tokyo researchers synthesized the patients’ real-world experiences with complex genetic disorders into a single case. The study reveals how compartmentalized care leads to treatment refusal and patient harm, while coordinated interdisciplinary teams can restore well-being. It highlights the urgent need for reforms in medical education, care continuity, and health policy to create more inclusive, patient-centered healthcare systems.
Emerging infectious diseases (EIDs), whether newly identified or re-emerging in human and animal populations, pose significant threats to global public health. China has experienced multiple EIDs outbreaks in recent years, underscoring the need for robust surveillance and early warning systems. Although China has established surveillance systems for events affecting climate, wildlife, livestock and poultry, and humans, the current systems remain inadequate for the early detection, monitoring, and prevention of zoonotic spillover events. The “One Health” approach, which integrates human, animal, and environmental health, offers a comprehensive strategy for mitigating EIDs risks. This study reviews China's national-level surveillance and early warning systems from a “One Health” perspective, highlighting key limitations and proposing future directions to enhance preparedness and response capabilities. The findings are intended to inform policy improvements and strengthen interdisciplinary collaboration for effective EIDs management.
The 2024 WHO Bacterial Priority Pathogens List (WHO BPPL) is a critical tool for refining global antimicrobial resistance (AMR) strategy, prioritizing 24 bacteria with a focus on Gram-negatives and community threats like Salmonella Typhi. This perspective examines its One Health implications. While the 2024 WHO BPPL effectively guides research and development (R&D), policy, and infection control through vaccines and water, sanitation and hygiene (WASH) programs, its human-centric approach underrepresents critical agricultural and environmental AMR drivers. Surveillance biases towards high-income countries and the inherent challenges of cross-sectoral monitoring—given the distinct niches of pathogens like Enterococcus faecium and Shigella—further limit its scope. We call for integrating zoonotic and environmental metrics, strengthening global surveillance (e.g., Global Antimicrobial Resistance and Use Surveillance System [GLASS]), and accelerating development of novel therapies to advance a more equitable and holistic AMR response.
A new machine learning tool has identified more than 250,000 cancer research papers that may have been produced by so-called “paper mills”.
A new peer-reviewed study evaluating climate policies in 40 countries over a 32-year period finds that carbon pricing and taxation—combined with investments in renewable energy and research—are among the most effective tools governments can use to reduce CO₂ emissions.